Purchase Order 75H71222P00084
- Not listed
- This is a firm fixed-price delivery order awarded by the Indian Health Service to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $450,000.00 contract is for the provision of CEPHEID SUPPLIES, with a period of performance through June 30, 2025. Cepheid is a prime contractor and has previously been awarded Indefinite Delivery Vehicles (IDVs) with the Indian Health Service and Department of Veterans Affairs for molecular diagnostic products and services, including...
- This is a firm fixed-price delivery order contract awarded by the Indian Health Service (IHS), a civilian agency, to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract is valued at $176,833.92 and covers the period from July 1, 2025, to June 30, 2026. Cepheid will provide the IHS with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and...
- This is a firm fixed-price purchase order awarded by the Indian Health Service to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, for the provision of a CEPHEID ANALYZER SERVICE QUOTE CSQN-00014185V3.0 for two GeneXpert diagnostic systems. The award has a ceiling value of $42,953.56 and an ultimate completion date of October 18, 2029. The contract does not have a set-aside designation. Cepheid is a prime contractor that has also been awarded several larger Indefinite...
- This is a firm fixed-price purchase order awarded by the Indian Health Service to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for a CEPHEID SERVICE AGREEMENT - GX16A1Y - GENEXPERT 16 MODULE SERIAL# 836819 with a period of performance from May 4, 2022, to May 3, 2023, and three one-year option years, for a total potential value of $124,266.37. The contract provides GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance...
- This is a firm fixed-price purchase order awarded by the Indian Health Service, a civilian agency, to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract is for the provision of 4 replacement CEPHEID units with a trade-in allowance, with a total ceiling value of $255,070.43 and a completion date of June 9, 2029. The contract does not have a set-aside designation. Cepheid is the prime contractor and has participated in other federal contract vehicles and...
- This is a firm fixed-price purchase order awarded by the Indian Health Service (IHS) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $27,229.00, is for a CEPHEID XPRESS 4X4 (BASE + 3 OY) diagnostic system and associated warranty. The contract does not have a set-aside designation. Cepheid is the prime contractor and manufacturer of the diagnostic equipment, which enables rapid, precise detection of infectious diseases such as COVID-19,...
- This is a firm fixed-price purchase order awarded by the Indian Health Service, a civilian federal agency, to Cepheid, a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The $59,235.71 contract is for the provision of Combined Cepheid Service, with an ultimate completion date of January 31, 2030. Cepheid is an experienced federal contractor, holding several significant Indefinite Delivery Vehicle (IDV) contracts with agencies such as the Department of...
- This federal contract award to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, is a delivery order valued at $196,959.10. The contract is with the Indian Health Service, a civilian agency under the Department of Health and Human Services. Cepheid will provide the agency with CEPHEID SUPPLIES, which includes GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza,...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Indian Health Service, a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $416,991.94, is for the supply of CEPHEID diagnostic products and has an ultimate completion date of July 30, 2025. The contract is a delivery order with a firm fixed-price pricing type and does not have a set-aside designation. Cepheid is the prime contractor...
- This federal contract award, worth $39,679.43, was issued by the Indian Health Service (IHS) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract is for a CEPHEID SERVICE AGREEMENT for molecular diagnostic testing systems, reagents, and associated maintenance services. This is not a set-aside contract. The award is part of larger Indefinite Delivery Vehicle (IDV) contracts that Cepheid holds with the Department of Veterans Affairs (VA) and IHS, valued at...
This is a firm fixed-price purchase order awarded by the Indian Health Service to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for a CEPHEID SERVICE AGREEMENT to reinstate service and provide a base year plus three option years, with a ceiling value of $32,600.00. The contract supports the Indian Health Service's clinical testing programs by providing Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and other conditions. This is not a set-aside contract. Cepheid has several significant federal contract Indefinite Delivery Vehicles with agencies like the Department of Veterans Affairs, enabling continuous procurement of its molecular diagnostic solutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Other Administrative Action | $0 | 4/21/25 | |
| P00003 | Exercise an Option | $6.9k | 4/2/25 | |
| P00002 | Exercise an Option | $6.9k | 4/9/24 | |
| P00001 | Exercise an Option | $6.9k | 3/24/23 | |
| Not listed | Not listed | $11.9k | 5/20/22 |